| 000 | 01877 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250512091741.0 | ||
| 264 | 0 | _c19750326 | |
| 008 | 197503s 0 0 eng d | ||
| 022 | _a0300-8584 | ||
| 024 | 7 |
_a10.1007/BF02121731 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFraser, K B | |
| 245 | 0 | 0 |
_aEnzyme treatment of unfixed cell cultures as a means of determining different specificities of immunoglobulin-M in multiple sclerosis and measles. _h[electronic resource] |
| 260 |
_bMedical microbiology and immunology _c1974 |
||
| 300 |
_a221-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAbsorption |
| 650 | 0 | 4 | _aAntibody Specificity |
| 650 | 0 | 4 | _aAntigens, Viral |
| 650 | 0 | 4 |
_aCardiolipins _xpharmacology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Membrane Permeability _xdrug effects |
| 650 | 0 | 4 | _aEpitopes |
| 650 | 0 | 4 |
_aErythrocytes _xdrug effects |
| 650 | 0 | 4 | _aFluorescent Antibody Technique |
| 650 | 0 | 4 | _aFormaldehyde |
| 650 | 0 | 4 | _aHemagglutination Tests |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmune Sera |
| 650 | 0 | 4 | _aImmunoglobulin M |
| 650 | 0 | 4 |
_aLipids _xisolation & purification |
| 650 | 0 | 4 |
_aLysophosphatidylcholines _xpharmacology |
| 650 | 0 | 4 |
_aMeasles _ximmunology |
| 650 | 0 | 4 |
_aMeasles virus _ximmunology |
| 650 | 0 | 4 |
_aMultiple Sclerosis _ximmunology |
| 650 | 0 | 4 |
_aMuramidase _xpharmacology |
| 650 | 0 | 4 |
_aPapain _xpharmacology |
| 650 | 0 | 4 |
_aPeriodic Acid _xpharmacology |
| 650 | 0 | 4 |
_aPhospholipases _xpharmacology |
| 650 | 0 | 4 |
_aPronase _xpharmacology |
| 650 | 0 | 4 |
_aSolvents _xpharmacology |
| 650 | 0 | 4 |
_aTrypsin _xpharmacology |
| 650 | 0 | 4 | _agamma-Globulins |
| 700 | 1 | _aShirodaria, P V | |
| 700 | 1 | _aHaire, M | |
| 773 | 0 |
_tMedical microbiology and immunology _gvol. 160 _gno. 2-3 _gp. 221-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02121731 _zAvailable from publisher's website |
| 999 |
_c4146581 _d4146581 |
||